Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Mar 03, 2022Mar 07, 2022Goldberg Mark Alan
Dir
BuyBlueprint Medicines CorpBPMC$59.98$299,900+31.62%
Dec 24, 2020Dec 28, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$125$681,875-60.50%
Dec 18, 2020Dec 22, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$120$654,480-60.49%
Dec 11, 2020Dec 15, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$115$627,325-60.50%
Dec 01, 2020Dec 03, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$110$599,940-60.49%
Oct 19, 2020Oct 21, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$105$572,775-60.50%
Oct 07, 2020Oct 09, 2020Goldberg Mark Alan
Dir
SellBlueprint Medicines CorpBPMC$100$545,400-60.49%
Dec 19, 2018Dec 20, 2018Goldberg Mark Alan
Dir
BuyIdera Pharmaceuticals, Inc.IDRA$3.19$31,897+50.00%
Nov 06, 2018Nov 07, 2018Goldberg Mark Alan
Dir
BuyImmunogen IncIMGN$5.76$172,800+35.80%
Dec 15, 2016Dec 15, 2016Goldberg Mark Alan
Dir
BuyImmunogen IncIMGN$1.8$36,000+45.66%
Mar 04, 2016Mar 07, 2016Goldberg Mark Alan
Dir
BuyGlycomimetics IncGLYC$4.77$49,630+47.49%
Aug 18, 2015Aug 19, 2015Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$73.49$661,043-8.15%
Jun 18, 2015Jun 19, 2015Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$70.03$805,835-10.19%
Mar 19, 2015Mar 20, 2015Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$68.99$888,867-11.28%
Dec 03, 2014Dec 05, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$58.99$1M-20.00%
Nov 28, 2014Dec 02, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$58.99$28,020-0.47%
Sep 19, 2014Sep 19, 2014Goldberg Mark Alan
EVP
Medical
Reg. Strategy
SellSynageva Biopharma CorpGEVA$65.24$51,540-58.43%
Sep 16, 2014Sep 18, 2014Goldberg Mark Alan
EVP
Medical
Reg. Strategy
SellSynageva Biopharma CorpGEVA$65.03$882,981-96.03%
Aug 13, 2014Aug 14, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$56.33$944,147-13.76%
Jun 11, 2014Jun 12, 2014Goldberg Mark Alan
EVP
Medical
Reg. Strategy
SellSynageva Biopharma CorpGEVA$80$2M-97.92%
Feb 18, 2014Feb 19, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$52.49$588,203-9.64%
Feb 12, 2014Feb 14, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$50.49$615,928-10.40%
Feb 03, 2014Feb 05, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$48.7$658,857-11.41%
Jan 13, 2014Jan 14, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$48.9$340,197-5.54%
Jan 09, 2014Jan 10, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$46.49$320,827-5.50%
Jan 08, 2014Jan 09, 2014Goldberg Mark A
Pres
COO
SellParexel International CorpPRXL$46.49$21,618-0.39%
Dec 03, 2013Dec 04, 2013Goldberg Mark Alan
SVP
Medical
Regulatory Affair
SellSynageva Biopharma CorpGEVA$60.52$423,649-96.33%
Nov 01, 2013Nov 04, 2013Goldberg Mark Alan
SVP
Medical
Regulatory Affair
SellSynageva Biopharma CorpGEVA$49.96$349,753-96.33%
Oct 01, 2013Oct 03, 2013Goldberg Mark Alan
SVP
Medical
Regulatory Affair
SellSynageva Biopharma CorpGEVA$64.31$450,203-96.33%